| Author (Person) | Jack, Andrew |
|---|---|
| Series Title | Financial Times |
| Series Details | 28.1.05 |
| Publication Date | 28/01/2005 |
| Content Type | News |
|
Thomas Lönngren, Director-General of the European Medicines Agency, has called for a shake-up in regulation of drug safety with more stringent monitoring and independently-funded research to identify problems with treatments in use by patients. |
|
| Related Links |
|
| Subject Categories | Business and Industry, Health |
| Countries / Regions | Europe |